Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine

Kleopatra H. Schulpis1 / Aglaia Giannoulia-Karantana2 / Evangelos D. Papaconstantinou3 / Theodore Parthimos4 / Ioanna Tjamouranis5 / Stylianos Tsakiris6

1.

2.

3.

4.

5.

6.

Corresponding author: Stylianos Tsakiris, PhD, Associate Professor, Department of Experimental Physiology, Medical School, University of Athens, P.O. Box 65257, 15401 Athens, Greece

Citation Information: Clinical Chemical Laboratory Medicine. Volume 44, Issue 4, Pages 423–427, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.069, April 2006

Publication History

Received:
October 25, 2005
Accepted:
January 3, 2006
Published Online:
2006-04-07

Abstract

Background: Increased homocysteine (Hcy) blood levels are correlated with vascular and neurological problems. The aim of our study was to investigate erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in patients with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype.

Methods: Blood was obtained from 25 patients before and after folic acid supplementation and from controls (n=30) once. Plasma folate, vitamin B12 and total antioxidant status (TAS) were measured using commercial kits, Hcy was determined by HPLC and membrane enzyme activities were measured spectrophotometrically.

Results: Mg2+-ATPase remained unaltered. Membrane Na+,K+-ATPase activity was remarkably increased in patients (0.77±0.06 μmol Pi/h × mg protein) and decreased to normal levels (0.52±0.05 μmol Pi/h × mg protein; p<0.001) after therapy. TAS did not differ significantly before and after treatment. Hcy levels were significantly higher before therapy (25.4±2.8 μmol/L) than levels after therapy (12.1±2.0 μmol/L; p<0.001) and in controls (10.5±2.5 μmol/L, p<0.001). In vitro, L-phenylalanine (Phe) reversed to normal the stimulated enzyme from patients before therapy. In addition, Phe incubation of the Hcy activated membrane Na+,K+-ATPase from controls resulted in restoration of its activity, whereas L-alanine (Ala) incubation protected the enzyme from Hcy activation.

Conclusions: The increased membrane Na+,K+-ATPase activity may be due to high -SH group Hcy levels. In vitro, Phe reversed the increase in enzyme activity induced by Hcy in controls, as well as the stimulated membrane enzyme in untreated patients. Ala protected the enzyme from Hcy action.

Keywords: L-alanine; erythrocyte membrane; hyperhomocysteinaemia; Na+,K+-ATPase; L-phenylalanine

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Charis Liapi, Argyro Kyriakaki, Apostolos Zarros, Hussam Al-Humadi, Vasileios Stolakis, Elena Gkrouzman, Foteini Anifantaki, Nikolina Skandali, Marios Margaritis, and Stylianos Tsakiris
Food and Chemical Toxicology, 2009, Volume 47, Number 1, Page 82
[2]
Irene Simintzi, Kleopatra H. Schulpis, Panagoula Angelogianni, Charis Liapi, and Stylianos Tsakiris
Toxicology, 2007, Volume 237, Number 1-3, Page 177
[3]
Charis Liapi, Irini Feskou, Apostolos Zarros, Haris Carageorgiou, Panagiota Galanopoulou, and Stylianos Tsakiris
Metabolic Brain Disease, 2008, Volume 23, Number 3, Page 289
[4]
Charis Liapi, Irini Feskou, Apostolos Zarros, Panagiota Galanopoulou, and Stylianos Tsakiris
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 5
[5]
Aleksandra Rašić-Marković, Olivera Stanojlović, Dragan Hrnčić, Danijela Krstić, Mirjana Čolović, Veselinka Šušić, Tatjana Radosavljević, and Dragan Djuric
Molecular and Cellular Biochemistry, 2009, Volume 327, Number 1-2, Page 39

Comments (0)

Please log in or register to comment.